Deciphering the Role of Adrenergic Receptors in Alzheimer’s Disease: Paving the Way for Innovative Therapies

Deciphering the Role of Adrenergic Receptors in Alzheimer’s Disease: Paving the Way for Innovative Therapies

Neurodegenerative diseases are currently among the most devastating diseases with no effective disease-modifying drugs in the market, with Alzheimer’s disease (AD) being the most prevalent. AD is a complex multifactorial neurodegenerative disorder characterized by progressive and severe cognitive im...

Full description

Saved in:

Bibliographic Details
Main Authors:	Androulla N. Miliotou, Andria Kotsoni, Lefteris C. Zacharia
Format:	Article
Language:	English
Published:	MDPI AG 2025-01-01
Series:	Biomolecules
Subjects:	adrenergic receptors Alzheimer’s disease neurodegeneration neuroinflammation tauopathies beta amyloid
Online Access:	https://www.mdpi.com/2218-273X/15/1/128
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Association between beta‐blocker atenolol use and prostate cancer upgrading in active surveillance1
by: Ali H. Zahalka, et al.
Published: (2024-11-01)

Molecular Mechanisms of Alzheimer’s Disease Induced by Amyloid-β and Tau Phosphorylation Along with RhoA Activity: Perspective of RhoA/Rho-Associated Protein Kinase Inhibitors for Neuronal Therapy
by: Eun Hee Ahn, et al.
Published: (2025-01-01)

Scrutinizing the evidence of anthracene toxicity on adrenergic receptor beta-2 and its bioremediation by fungal manganese peroxidase via in silico approaches
by: Muhammad Naveed, et al.
Published: (2025-01-01)

Delta-opioid receptor signaling alleviates neuropathology and cognitive impairment in the mouse model of Alzheimer’s disease by regulating microglia homeostasis and inhibiting HMGB1 pathway
by: Yuan Xu, et al.
Published: (2025-02-01)

Neuroprotective role of epigallocatechin-3-gallate, albeginin and melanoxetin in alzheimer's disease
by: Arif Malik, et al.
Published: (2025-02-01)

Brain targeting based nanocarriers loaded with resveratrol in Alzheimer's disease: A review
by: Cyrus Jalili, et al.
Published: (2023-05-01)

Prion meeting 2023: implications of a growing field
by: Tiago F. Outeiro, et al.
Published: (2024-12-01)

Lipidopathy disrupts peripheral and central amyloid clearance in Alzheimer's disease: Where are our knowledge
by: Shahram Darabi, et al.
Published: (2025-06-01)

Multifaceted neuroprotective effects of (-)-epigallocatechin-3-gallate (EGCG) in Alzheimer’s disease: an overview of pre-clinical studies focused on β-amyloid peptide
by: Kumju Youn, et al.
Published: (2022-05-01)

CD22 modulation alleviates amyloid β-induced neuroinflammation
by: Yu Dong Mai, et al.
Published: (2025-02-01)

The Science of Memory Loss: Insights into Alzheimer’s Disease
by: Agnieszka Starzyk, et al.
Published: (2025-02-01)

SIRT2 and ALDH1A1 as critical enzymes for astrocytic GABA production in Alzheimer’s disease
by: Mridula Bhalla, et al.
Published: (2025-01-01)

Diagnosis and Treatment of Alzheimer’s Disease: Current Update
by: Younghee Yim, et al.
Published: (2025-01-01)

Mechanistic insights into connexin-mediated neuroglia crosstalk in neurodegenerative diseases
by: Simona Denaro, et al.
Published: (2025-02-01)

The aptamer BC 007 for treatment of dilated cardiomyopathy: evaluation in Doberman Pinschers of efficacy and outcomes
by: Sabine Werner, et al.
Published: (2020-06-01)

Screening of Aβ and phosphorylated tau status in the cerebrospinal fluid through machine learning analysis of portable electroencephalography data
by: Masahiro Hata, et al.
Published: (2025-01-01)

Human Endogenous Retroviruses and Their Putative Role in Pathogenesis of Alzheimer’s Disease, Inflammation, and Senescence
by: Patrycja Kozubek, et al.
Published: (2024-12-01)

Isoforsythiaside confers neuroprotection against Alzheimer’s disease by attenuating ferroptosis and neuroinflammation in vivo and in vitro
by: Chunyue Wang, et al.
Published: (2023-09-01)

RIPK1 expression and inhibition in tauopathies: implications for neuroinflammation and neuroprotection
by: Ignacio Silva-Llanes, et al.
Published: (2025-01-01)

Hypertension moderates the relationship between plasma beta-amyloid and cognitive impairment: a cross-sectional study in Xi’an, China
by: Ziyu Liu, et al.
Published: (2025-01-01)

Mutations in human prion-like domains: pathogenic but not always amyloidogenic
by: Andrea Bartolomé-Nafría, et al.
Published: (2024-12-01)

Insufficient Sleep and Alzheimer’s Disease: Potential Approach for Therapeutic Treatment Methods
by: Dieu Quynh Trinh, et al.
Published: (2024-12-01)

Editorial: 15 years of Frontiers in Cellular Neuroscience: the dual role of microglia in (neuro)inflammation
by: Antonio J. Herrera, et al.
Published: (2025-02-01)

Inflammasomes in neurodegenerative diseases
by: Qianchen Wang, et al.
Published: (2024-12-01)

Alzheimer's disease and gut-brain axis: Drosophila melanogaster as a model
by: Samuel de Mattos Alves, et al.
Published: (2025-02-01)

Amyloid-β and heart failure in Alzheimer’s disease: the new vistas
by: Hayder M. Al-Kuraishy, et al.
Published: (2025-02-01)

The neurotoxicity of iodoacetic acid, a byproduct of drinking water disinfection
by: Xu Wang, et al.
Published: (2025-01-01)

Functional and effective EEG connectivity patterns in Alzheimer’s disease and mild cognitive impairment: a systematic review
by: Elizabeth R. Paitel, et al.
Published: (2025-02-01)

A study to determine the effect of nano-selenium and thymoquinone on the Nrf2 gene expression in Alzheimer’s disease
by: Doha El-Sayed Ellakwa, et al.
Published: (2025-12-01)

Amyloid-Related Imaging Abnormalities in Anti-Amyloid Monoclonal Antibody Therapy for Alzheimer’s Disease: Expert Recommendation for Standard MRI Protocol
by: Jimin Kim, et al.
Published: (2025-01-01)

Lipid mediators in post-mortem brain samples from patients with Alzheimer's disease: A systematic review
by: Aidan D. Tyrrell, et al.
Published: (2025-02-01)

Current Status of Plant-Based Bioactive Compounds as Therapeutics in Alzheimer’s Diseases
by: Dan Chen, et al.
Published: (2025-01-01)

Pragmatic algorithm for visual assessment of 4-Repeat tauopathies in [18F]PI-2620 PET Scans
by: Theresa Bauer, et al.
Published: (2025-02-01)

In search of Alzheimer’s disease treatment methods: trends of clinical trials
by: G. Pakulaitė, et al.
Published: (2018-03-01)

Microvascular dysfunction in a murine model of Alzheimer’s disease using intravital microscopy
by: Danielle Sidsworth, et al.
Published: (2025-02-01)

Structural Analysis of Amylin and Amyloid β Peptide Signaling in Alzheimer’s Disease
by: Longsheng Xie, et al.
Published: (2025-01-01)

Developing non-invasive molecular markers for early risk assessment of Alzheimer's disease
by: Tapas K. Sur, et al.
Published: (2025-06-01)

Bis(7)-harmine derivatives as potential multi-target anti-Alzheimer agents
by: Hongtao Du, et al.
Published: (2025-01-01)

Second-generation anti-amyloid monoclonal antibodies for Alzheimer’s disease: current landscape and future perspectives
by: Byeong-Hyeon Kim, et al.
Published: (2025-01-01)

Oligodendrocyte Injury in Multiple Sclerosis.
by: Mateo Përgjegji, et al.
Published: (2025-01-01)